Cost-effectiveness of a RE-AIM-Informed Autonomy-Competence Intervention to Improve Medication Adherence and Quality of Life Among Patients With Heart Failure

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversiti Putra Malaysia

About this trial

Medication non-adherence leads to recurrent admissions, worsening symptoms, poor quality of life, and increased healthcare costs in an already overburdened health system. Existing adherence interventions in Pakistan are limited, mostly educational, and rarely guided by behavioural theory, implementation science, or economic evaluation.

Therefore, a culturally appropriate, RE-AIM-informed autonomy-competence intervention is needed to improve medication adherence and quality of life among heart failure patients in Pakistan, while also assessing implementation feasibility and cost-effectiveness for future scale-up.

Eligibility criteria

Qualifiers

Age ≥18 years

Diagnosed heart failure for at least 6 months

Prescribed ≥2 heart failure medications

Documented medication non-adherence

Disqualifiers

Severe psychiatric illness

Terminal illness

Severe cognitive impairment

End-stage renal disease

Trial design

Treatments tested in this trial

  • RE-AIM-informed autonomy-competence intervention

Treatment groups

870 Participants
are divided into 2 treatment groups

Sponsors and collaborators